Genetic and phenotypic spectrum in the NONO-associated syndromic disorder.

RNA expression analysis X-linked inheritance corpus callosum anomalies in-frame splice deletion neurodevelopmental delay non-compaction cardiomyopathy

Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
02 2023
Historique:
revised: 23 09 2022
received: 23 05 2022
accepted: 30 09 2022
pubmed: 26 11 2022
medline: 13 1 2023
entrez: 25 11 2022
Statut: ppublish

Résumé

The non-POU domain-containing octamer-binding (NONO) protein is involved in multiple steps of gene regulation such as RNA metabolism and DNA repair. Hemizygous pathogenic variants in the NONO gene were confirmed to cause a rare X-linked syndromic disorder. Through our in-house diagnostics and subsequent matchmaking, we identified six unrelated male individuals with pathogenic or likely pathogenic NONO variants. For a detailed comparison, we reviewed all published characterizations of the NONO-associated disorder. The combined cohort consists of 16 live-born males showing developmental delay, corpus callosum anomalies, non-compaction cardiomyopathy and relative macrocephaly as leading symptoms. Seven prenatal literature cases were characterized by cardiac malformations. In this study, we extend the phenotypic spectrum through two more cases with epilepsy as well as two more cases with hematologic anomalies. By RNA expression analysis and structural modeling of a new in-frame splice deletion, we reinforce loss-of-function as the pathomechanism for the NONO-associated syndromic disorder.

Identifiants

pubmed: 36426740
doi: 10.1002/ajmg.a.63044
doi:

Substances chimiques

DNA-Binding Proteins 0
RNA 63231-63-0
NONO protein, human 0
RNA-Binding Proteins 0

Types de publication

Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

469-478

Informations de copyright

© 2022 The Authors. American Journal of Medical Genetics Part A published by Wiley Periodicals LLC.

Références

Carlston, C. M., Bleyl, S. B., Andrews, A., Meyers, L., Brown, S., Bayrak-Toydemir, P., Bale, J. F., & Botto, L. D. (2019). Expanding the genetic and clinical spectrum of the NONO-associated X-linked intellectual disability syndrome. American Journal of Medical Genetics Part A, 179(5), 792-796. https://doi.org/10.1002/ajmg.a.61091
Carmody, L., Vasilevsky, N., Jacobsen, J. O., Danis, D., Gourdine, J.-P., Gargano, M., Harris, N. L., Matentzoglu, N., McMurry, J. A., Osumi-Sutherland, D., Cipriani, V., Balhoff, J. P., Conlin, T., Blau, H., Baynam, G., Palmer, R., Gratian, D., Dawkins, H., Segal, M., … Robinson, P. N. (2019). Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources. Nucleic Acids Research, 47, D1018-D1027. https://doi.org/10.1093/nar/gky1105
Chin, T. K., Perloff, J. K., Williams, R. G., Jue, K., & Mohrmann, R. (1990). Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation, 82(2), 507-513. https://doi.org/10.1161/01.CIR.82.2.507
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., Gauthier, L. D., Brand, H., Solomonson, M., Watts, N. A., Rhodes, D., Singer-Berk, M., England, E. M., Seaby, E. G., Kosmicki, J. A., … MacArthur, D. G. (2020). The mutational constraint spectrum quantified from variation in 141,456 humans. Nature, 581(7809), 434-443. https://doi.org/10.1038/s41586-020-2308-7
Khan, A., & Mathelier, A. (2017). Intervene: A tool for intersection and visualization of multiple gene or genomic region sets. BioMed Central Bioinformatics, 18(1), 287. https://doi.org/10.1186/S12859-017-1708-7
Knott, G. J., Bond, C. S., & Fox, A. H. (2016). The DBHS proteins SFPQ, NONO and PSPC1: A multipurpose molecular scaffold. Nucleic Acids Research, 44(9), 3989-4004. https://doi.org/10.1093/nar/gkw271
Landrum, M. J., Lee, J. M., Riley, G. R., Jang, W., Rubinstein, W. S., Church, D. M., & Maglott, D. R. (2014). ClinVar: Public archive of relationships among sequence variation and human phenotype. Nucleic Acids Research, 42, D980-D985. https://doi.org/10.1093/NAR/GKT1113
Lex, A. (2014). Sets and intersections. Nature Methods, 11(8), 779. https://doi.org/10.1038/NMETH.3033
Mircsof, D., Langouët, M., Rio, M., Moutton, S., Siquier-Pernet, K., Bole-Feysot, C., Cagnard, N., Nitschke, P., Gaspar, L., Žnidariɥ, M., Alibeu, O., Fritz, A. K., Wolfer, D. P., Schröter, A., Bosshard, G., Rudin, M., Koester, C., Crestani, F., Seebeck, P., … Colleaux, L. (2015). Mutations in NONO lead to syndromic intellectual disability and inhibitory synaptic defects. Nature Neuroscience, 18(12), 1731-1736. https://doi.org/10.1038/nn.4169
Osuchukwu, O. O., & Reed, D. J. (2022). Small for gestational age. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK563247/
Passon, D. M., Lee, M., Rackham, O., Stanley, W. A., Sadowska, A., Filipovska, A., Fox, A. H., & Bond, C. S. (2012). Structure of the heterodimer of human NONO and paraspeckle protein component 1 and analysis of its role in subnuclear body formation. Proceedings of the National Academy of Sciences of the United States of America, 109(13), 4846-4850. https://doi.org/10.1073/PNAS.1120792109
Popp, M. W., & Maquat, L. E. (2016). Leveraging rules of nonsense-mediated mRNA decay for genome engineering and personalized medicine. Cell, 165(6), 1319-1322. https://doi.org/10.1016/J.CELL.2016.05.053
Reinstein, E., Tzur, S., Cohen, R., Bormans, C., & Behar, D. M. (2016). Intellectual disability and non-compaction cardiomyopathy with a de novo NONO mutation identified by exome sequencing. European Journal of Human Genetics, 24(11), 1635-1638. https://doi.org/10.1038/ejhg.2016.72
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., & Rehm, H. L. (2015). Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine, 17(5), 405-423. https://doi.org/10.1038/gim.2015.30
Scott, D. A., Hernandez-Garcia, A., Azamian, M. S., Jordan, V. K., Kim, B. J., Starkovich, M., Zhang, J., Wong, L. J., Darilek, S. A., Breman, A. M., Yang, Y., Lupski, J. R., Jiwani, A. K., Das, B., Lalani, S. R., Iglesias, A. D., Rosenfeld, J. A., & Xia, F. (2017). Congenital heart defects and left ventricular non-compaction in males with loss-of-function variants in NONO. Journal of Medical Genetics, 54(1), 47-53. https://doi.org/10.1136/jmedgenet-2016-104039
Sewani, M., Nugent, K., Blackburn, P. R., Tarnowski, J. M., Hernandez-Garcia, A., Amiel, J., Whalen, S., Keren, B., Courtin, T., Rosenfeld, J. A., Yang, Y., Patterson, M. C., Pichurin, P., McLean, S. D., & Scott, D. A. (2020). Further delineation of the phenotypic spectrum associated with hemizygous loss-of-function variants in NONO. American Journal of Medical Genetics, Part A, 182(4), 652-658. https://doi.org/10.1002/ajmg.a.61466
Sun, H., Han, L., Zhang, X., Hao, X., Zhou, X., Pan, R., Zhang, H., & He, Y. (2020). Case report: Characterization of a novel NONO intronic mutation in a fetus with X-linked syndromic mental Retardation-34. Frontiers in Genetics, 11, 593688. https://doi.org/10.3389/fgene.2020.593688
Sun, H., Zhou, X., Hao, X., Zhang, Y., Zhang, H., & He, Y. (2020). Characteristics of cardiac phenotype in prenatal familial cases with NONO mutations. Circulation: Genomic and Precision Medicine, 13(3), e002847. https://doi.org/10.1161/CIRCGEN.119.002847
Wiel, L., Baakman, C., Gilissen, D., Veltman, J. A., Vriend, G., & Gilissen, C. (2019). Meta Dome: Pathogenicity analysis of genetic variants through aggregation of homologous human protein domains. Human Mutation, 40(8), 1030-1038. https://doi.org/10.1002/HUMU.23798

Auteurs

Franziska Roessler (F)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.

Anita E Beck (AE)

Division of Genetic Medicine, Department of Pediatrics, University of Washington, Seattle, Washington, USA.
Seattle Children's Hospital, Seattle, Washington, USA.

Ball Susie (B)

Central Washington Genetics Program, Yakima Valley Memorial, Yakima, Washington, USA.

Bartolomaeus Tobias (B)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.

Amber Begtrup (A)

GeneDx, Gaithersburg, Maryland, USA.

Saskia Biskup (S)

Praxis für Humangenetik, Tübingen, Germany.

Oana Caluseriu (O)

Department of Medical Genetics, University of Alberta, Edmonton, Alberta, Canada.

Norman Delanty (N)

FutureNeuro SFI Research Centre, The Royal College of Surgeons in Ireland, Dublin, Ireland.
Department of Neurology, Beaumont Hospital, Dublin, Ireland.

Christine Fröhlich (C)

Praxis für Humangenetik, Tübingen, Germany.

Marie T Greally (MT)

FutureNeuro SFI Research Centre, The Royal College of Surgeons in Ireland, Dublin, Ireland.
School of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.

Maike Karnstedt (M)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.

Chiara Klöckner (C)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.

Joanne Kurtzberg (J)

Marcus Center for Cellular Cures, Duke University School of Medicine, Durham, North Carolina, USA.

Susanna Schubert (S)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.

Martin Schulze (M)

Praxis für Humangenetik, Tübingen, Germany.

Michael Weidenbach (M)

Department for Pediatric Cardiology, Heart Center Leipzig, University of Leipzig, Leipzig, Germany.

Dominik S Westphal (DS)

Institute of Human Genetics, Klinikum Rechts der Isar, School of Medicine, Technical University Munich, Germany.
Department of Internal Medicine I, Klinikum Rechts der Isar, School of Medicine, Technical University Munich, Munich, Germany.

Maire White (M)

FutureNeuro SFI Research Centre, The Royal College of Surgeons in Ireland, Dublin, Ireland.
School of Pharmacy and Biomolecular Sciences, The Royal College of Surgeons in Ireland, Dublin, Ireland.

Cordula M Wolf (CM)

Department of Congenital Heart Defects and Pediatric Cardiology, German Heart Center Munich, Technical University of Munich, School of Medicine and Health, DZHK (German Centre for Cardiovascular Research), Munich Heart Alliance, Munich, Germany.

Jacob Zyskind (J)

GeneDx, Gaithersburg, Maryland, USA.

Bernt Popp (B)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.

Vincent Strehlow (V)

Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH